TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05259306

Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“Indefinite hold due to administrative issues.”

The sponsor’s own words in the registry.

Life of this trial

20222023202420252026202720282029Registered2022-01-18Suspended (as of)2026-04-02Started2027-06 (planned)Primary completion2028-06 (planned)

Vital statistics

Status
Suspended
Phase
Na
Sponsor
NYU Langone Health
Sponsor type
University, hospital or other
Conditions
Treatment-resistant Schizophrenia
Interventions
Insightec Exablate Neuro MR-guided focused ultrasound transducer
Participants
3 (planned, not actual)
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.